Acadia Pharmaceuticals Inc (ACAD):企業の財務・戦略的SWOT分析

◆英語タイトル:Acadia Pharmaceuticals Inc (ACAD) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH66258FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Acadia Pharmaceuticals Inc (ACAD) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Acadia Pharmaceuticals Inc (Acadia) discovers, develops and commercializes small molecule drugs for the treatment of central nervous system (CNS) disorders. The company’s marketed product Nuplazid (pimavanserin) is an FDA approved drug for the treatment of Parkinson’s disease psychosis. The company’s pipeline includes pimavanserin for the treatment of various indications which include Schizophrenia, Major Depressive Disorder (MDD), dementia-related psychosis (DRP), and trofinetide for the treatment of Rett Syndrome. The company markets its product in the US. It has operational presence in Denmark, Switzerland and the UK. Acadia is headquartered in San Diego, California, the US.

Acadia Pharmaceuticals Inc Key Recent Developments

Mar 31,2021: Geisinger Health, Acadia partner to build new facilities in Pennsylvania
Feb 24,2021: Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results
Feb 19,2021: Acadia Pharmaceuticals recognizes National Caregiver’s Day with launch of MoreThanMemoryLoss.com
Feb 10,2021: Acadia Pharmaceuticals to Announce Fourth Quarter and Full Year 2020 Financial Results on February 24, 2021
Jan 27,2021: Acadia Pharmaceuticals announces Commercial Leadership Change

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Acadia Pharmaceuticals Inc – Key Facts
Acadia Pharmaceuticals Inc – Key Employees
Acadia Pharmaceuticals Inc – Key Employee Biographies
Acadia Pharmaceuticals Inc – Major Products and Services
Acadia Pharmaceuticals Inc – History
Acadia Pharmaceuticals Inc – Company Statement
Acadia Pharmaceuticals Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Acadia Pharmaceuticals Inc – Business Description
Acadia Pharmaceuticals Inc – Corporate Strategy
Acadia Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Acadia Pharmaceuticals Inc – Strengths
Acadia Pharmaceuticals Inc – Weaknesses
Acadia Pharmaceuticals Inc – Opportunities
Acadia Pharmaceuticals Inc – Threats
Acadia Pharmaceuticals Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Acadia Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Acadia Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Acadia Pharmaceuticals Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 31, 2021: Geisinger Health, Acadia partner to build new facilities in Pennsylvania
Feb 24, 2021: Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results
Feb 19, 2021: Acadia Pharmaceuticals recognizes National Caregiver’s Day with launch of MoreThanMemoryLoss.com
Feb 10, 2021: Acadia Pharmaceuticals to Announce Fourth Quarter and Full Year 2020 Financial Results on February 24, 2021
Jan 27, 2021: Acadia Pharmaceuticals announces Commercial Leadership Change
Nov 04, 2020: Acadia Pharmaceuticals reports third quarter 2020 financial results
Nov 04, 2020: Acadia Pharmaceuticals to Announce Third Quarter 2020 Financial Results on November 4, 2020
Oct 06, 2020: Michael J. Fox Foundation and Acadia Pharmaceuticals partner to share resources and foster dialogue on cognitive changes and other non-motor symptoms in Parkinson’s disease
Oct 01, 2020: Acadia Pharmaceuticals appoints Elizabeth Garofalo, M.D. to Board of Directors
Aug 31, 2020: ACADIA Pharmaceuticals appoints Gudarz Davar, M.D., as Executive Vice President and Head of Research and Development
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Acadia Pharmaceuticals Inc, Key Facts
Acadia Pharmaceuticals Inc, Key Employees
Acadia Pharmaceuticals Inc, Key Employee Biographies
Acadia Pharmaceuticals Inc, Major Products and Services
Acadia Pharmaceuticals Inc, History
Acadia Pharmaceuticals Inc, Other Locations
Acadia Pharmaceuticals Inc, Subsidiaries
Acadia Pharmaceuticals Inc, Key Competitors
Acadia Pharmaceuticals Inc, Ratios based on current share price
Acadia Pharmaceuticals Inc, Annual Ratios
Acadia Pharmaceuticals Inc, Annual Ratios (Cont...1)
Acadia Pharmaceuticals Inc, Interim Ratios
Acadia Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Acadia Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Acadia Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Acadia Pharmaceuticals Inc (ACAD):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Abengoa SA (ABG)-エネルギー分野:企業M&A・提携分析
    Summary Abengoa, S.A. (Abengoa) is a manufacturer of applied engineering and equipment. The company provides integrated project solutions, including engineering and operation and maintenance services for conventional and renewable energy, infrastructure, and water desalination projects. Through long …
  • Toray Industries, Inc.:企業の戦略・SWOT・財務分析
    Toray Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary Toray Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Axelar AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Axelar AB (Axelar) is a drug development company that develops various novel anti-cancer treatments. The company lead drug candidateAXL1717 is used for the treatmentof non-small cell lung cancer. It also offers treatments for disease such as glioblastoma, sarcoma, malignant melanoma and mult …
  • Sparton Resources Inc (SRI):企業の財務・戦略的SWOT分析
    Summary Sparton Resources Inc (Sparton Resources) is a diversified company that acquires and develops oil and gas properties in North America and China. The company’s products include vanadium, natural gas, crude oil, gold, and vanadium flow batteries, among others. Its energy projects comprise Sier …
  • Huber+Suhner AG (HUBN):企業の財務・戦略的SWOT分析
    Huber+Suhner AG (HUBN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Earle M. Jorgensen Company:企業の戦略・SWOT・財務分析
    Earle M. Jorgensen Company - Strategy, SWOT and Corporate Finance Report Summary Earle M. Jorgensen Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Mitsubishi Electric Corporation:企業のM&A・事業提携・投資動向
    Mitsubishi Electric Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mitsubishi Electric Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • PT. Bank Rakyat Indonesia (Persero) Tbk.:戦略・SWOT・企業財務分析
    PT. Bank Rakyat Indonesia (Persero) Tbk. - Strategy, SWOT and Corporate Finance Report Summary PT. Bank Rakyat Indonesia (Persero) Tbk. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Prologis, Inc.:戦略・SWOT・企業財務分析
    Prologis, Inc. - Strategy, SWOT and Corporate Finance Report Summary Prologis, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Sino-Ocean Land Holdings Limited:戦略・SWOT・企業財務分析
    Sino-Ocean Land Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Sino-Ocean Land Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Lekoil Ltd (LEK):企業の財務・戦略的SWOT分析
    Summary Lekoil Ltd (Lekoil) is an oil and gas exploration and production company with interests in Nigeria and Namibia. The company owns oil and gas exploration and production properties such as Otakikpo marginal field, Nigeria Dahomey Basin OPL310 and Nigeria Dahomey Basin OPL 325 in Nigeria, and B …
  • Gridsum Holding, Inc. (GSUM):企業の財務・戦略的SWOT分析
    Gridsum Holding, Inc. (GSUM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Alliance Resource Partners LP:企業の戦略・SWOT・財務情報
    Alliance Resource Partners LP - Strategy, SWOT and Corporate Finance Report Summary Alliance Resource Partners LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • E-L Financial Corporation Limited:企業の戦略・SWOT・財務情報
    E-L Financial Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary E-L Financial Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Verizon Communications Inc (VZ):企業の財務・戦略的SWOT分析
    Verizon Communications Inc (VZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Heidelberger Druckmaschinen AG:企業の戦略・SWOT・財務情報
    Heidelberger Druckmaschinen AG - Strategy, SWOT and Corporate Finance Report Summary Heidelberger Druckmaschinen AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Nuevolution AB (NUE):製薬・医療:M&Aディール及び事業提携情報
    Summary Nuevolution AB (Nuevolution) is a biopharmaceutical company focused on developing drug treatments for cancer and chronic inflammatory diseases. The company’s pipeline products include RORyt inhibitor, BRD (BD1), cytokine X, RORyt agonist, and GRP78. Its products are used for various indicati …
  • GTx Inc (GTXI):製薬・医療:M&Aディール及び事業提携情報
    Summary GTx Inc (GTx) is a biopharmaceutical company that discovers, develops and commercializes novel targeted hormonal therapies. It develops small molecules that targets hormone pathways for the treatment of various cancers including breast and prostate cancer; and other serious medical condition …
  • Clinicient Inc-医療機器分野:企業M&A・提携分析
    Summary Clinicient Inc (Clinicient) is a healthcare technology company that offers EMR management and therapy practice solutions. The company offers insight platform software that offers single system created exclusively for outpatient rehab that populates data across both the clinical and financial …
  • Rubis SCA (RUI):石油・ガス:M&Aディール及び事業提携情報
    Summary Rubis SCA (Rubis) is an independent downstream company that carries out the storage, distribution and trading of bulk petroleum and chemical products. Its product portfolio includes fuel oil, liquefied petroleum gas (LPG), gasoline, diesel, home heating oil, chemical products, edible oils, m …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆